Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulmonary toxoplasmosis.

T G Evans1, J D Schwartzman

  • 1Division of Infectious Diseases, University of Utah, Salt Lake City 84132.

Seminars in Respiratory Infections
|March 1, 1991
PubMed
Summary
This summary is machine-generated.

Pulmonary toxoplasmosis, caused by Toxoplasma gondii, primarily affects immunocompromised individuals, leading to pneumonia. Early diagnosis and effective cell-mediated immunity are crucial for controlling this rare but serious infection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reasons for optimism in the search for new vaccines for tuberculosis.

Epidemiology and infection·2017
Same author

Pharmacokinetics and unexpected safety issues of LBM415, a novel oral peptide deformylase inhibitor.

Clinical pharmacology and therapeutics·2011
Same author

Oral sepsis and its treatment.

The British journal of physical medicine : including its application to industry·2010
Same author

A CASE OF PERTHES'S DISEASE OF THE HIP.

British medical journal·2010
Same author

Co-ordination of osmotic stress responses through osmosensing and signal transduction events in fishes.

Journal of fish biology·2010
Same author

Use of fish liver PLHC-1 cells and zebrafish embryos in cytotoxicity assays.

Methods (San Diego, Calif.)·2005

Area of Science:

  • Infectious Diseases
  • Immunology
  • Pulmonology

Background:

  • Pulmonary toxoplasmosis, caused by *Toxoplasma gondii*, is an uncommon but severe condition.
  • The lungs are frequently infected, but symptomatic disease is rare, typically occurring in immunocompromised patients.
  • Risk groups include transplant recipients and individuals with acquired immunodeficiency syndrome (AIDS).

Purpose of the Study:

  • To discuss the pathogenesis of pulmonary toxoplasmosis.
  • To highlight the importance of early diagnosis in at-risk populations.
  • To review host defense mechanisms against *Toxoplasma gondii* infection in the lungs.

Main Methods:

  • Review of *Toxoplasma gondii* invasion mechanisms.
  • Discussion of host immune evasion strategies employed by the protozoan.

Related Experiment Videos

  • Analysis of factors influencing disease outcome, including cell-mediated immunity.

    • Main Results:

    • *Toxoplasma gondii* invades cells, evades host defenses, and causes tissue necrosis.
    • Replication into destructive tachyzoites is driven by inadequate cell-mediated immunity.
    • Alveolar macrophages and gamma interferon are key effector mechanisms for controlling infection.

    Conclusions:

    • Symptomatic pulmonary toxoplasmosis requires high clinical suspicion in immunocompromised patients.
    • Early diagnosis is critical for improving patient outcomes.
    • Effective cell-mediated immunity is essential for preventing severe disease progression.